Default company panoramic image

Brazilian Biologics

Builing Biopharmaceutical Infrastructure for Brazil's Growing Needs

  • Stage Concept Only
  • Industry Not Set
  • Location New York City, NY, USA
  • Currency USD

Company Summary

Brazilian Biologics will revolutionize the biotech sector in Brazil by establishing the premier biopharmaceutical company in Brazil dedicated to the development and manufacturing of biopharmaceutical products. Brazilian Biologics provides the required infrastructure via a holsitic approach: Contract Manufacturing for Biologics (the first in Brazil and Latin America) and a Product Company. Our customers are Brazilian & Int'l Pharma Companies.


  • Default avatar
    Lisa M. Rhoads
    President / CEO

    Lisa joined Easton Capital in 2010 when she repatriated from Bermuda. Lisa was previously with Celtic Pharma, a Bermuda-based global biotech private equity firm, from 2003 2010 where she was a founding member of the management team. Lisa's spent the last seven years acquiring and developing a portfolio of later-stage biotech programs where she was involved with all aspects of the development process and managed Intellectual Property portfolio. Li

  • Default avatar
    Howard L. Levine
    Chief Operating Officer (COO)

    Howard is currently President and Principal Consultant of BioProcess Technology Consultants as well as Managing Director of BPTC Europe, a wholly owned subsidiary of BioProcess Technology Consultants. Howard has over 30 years of experience in the biopharmaceutical industry and has participated in the development and commercialization of several biopharmaceutical products. Prior to founding BioProcess Technology Consultants to provide technical an